Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Combs currently holds 230,000 shares of Prelude Therapeutics Inc (PRLD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Combs has been a net buyer of PRLD stock. They have purchased $113.9K and sold $0 worth of shares.
Andrew Combs's most recent insider trade was on Feb 4, 2026, when they sold 230,000 shares at $0.00 per share.
Andrew Combs serves as Executive at Prelude Therapeutics Inc (PRLD). They have executed 6 insider transactions totaling $113.9K over their tenure at the company.
Andrew Combs holds the position of Executive at Prelude Therapeutics Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Andrew Combs has shown a buying trading pattern, with $113.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Combs was on Mar 31, 2022, when they sold $68.2K worth of PRLD shares. This transaction involved 36,062 shares at $1.89 per share.
Andrew Combs currently owns 230,000 shares of Prelude Therapeutics Inc (PRLD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Combs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Combs has 6 Form 4 filings on record as an insider at Prelude Therapeutics Inc.
Set alerts for Andrew Combs and 40,000+ other insiders.